At Savills, our dedicated Life Sciences team understands the complexities of life sciences – the intense competition for talent and space, the need to balance your vision with your runway, and the infrastructure required to support the science.

Some of the exercises and solutions we offer our clients during this time include:

• Re-imagining lab workflows early on for efficient use of space
• Utilizing the sublet market to offload unutilized space
• Phasing your construction to make the most out of the tenant improvement allowance
• Identifying your team of strategic partners early in the process to create a reliable and efficient real estate plan
• Bringing in workplace experts to create compelling workspaces for employee retention

Following the surge of Life Science investments from 2020 through 2022, funding for these companies has slowed in the last year, causing organizations to make strategic decisions to extend their cash runways further. Although it may be viewed as a downswing in the sector, many experts view it as an opportunity to pivot and embrace a return to the “new normal”. Herein, we look to provide a unique lens into the pendulum swing of rapid growth over the last several years, to the rapid deceleration we are seeing now. Moreover, we'll describe the impact the pandemic and public markets are placing on real estate and offer a glimpse at solutions that can show how life science companies can adapt to the current environment.

Download the full report

Opinions expressed by the author are their own.